We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ALD:ASXAmpol Limited Analysis

Data as of 2026-03-11 - not real-time

A$29.42

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Ampol Limited has delivered a dramatic earnings turnaround in FY2025, with net profit jumping 83% and the dividend being raised, while forward earnings are projected to rise sharply to an EPS of 2.20 and a forward P/E of ~13, suggesting strong growth momentum. However, the stock trades at a trailing P/E of 86.5 versus an industry average of 20.7 and a DCF fair value of only $15, indicating that current pricing is heavily stretched. The company’s free cash flow remains negative and the payout ratio exceeds 100%, raising concerns about the sustainability of the 4.08% dividend yield. Technical indicators are mixed: the price sits between the 20‑day (29.26) and 50‑day (29.68) moving averages, the RSI is neutral at 49, but the MACD histogram is bullish (+0.19) and volume is increasing, keeping short‑term upside to the $32.7 resistance plausible. Risk factors include high volatility (38.8% 30‑day), modest beta (0.41), ongoing regulatory scrutiny of the EG Australia acquisition, and cash‑flow constraints, which temper the bullish fundamentals. Overall, the stock offers attractive dividend yield and growth prospects but appears overvalued at current levels, suggesting a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram
  • Increasing trading volume
  • Price near support level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong earnings turnaround and forward EPS growth
  • Forward P/E compression to ~13
  • Attractive dividend yield despite sustainability concerns

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • High current valuation relative to DCF
  • Regulatory scrutiny of acquisition plans
  • Cash flow constraints limiting dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth-3.40%
Profit Margin0.26%
P/E Ratio86.5
ROE3.89%
ROA2.83%
Debt/Equity122.04
P/B Ratio2.3
Op. Cash FlowA$794.8M
Free Cash FlowA$-176550000
Industry P/E20.7

Technical Analysis

TrendNeutral
RSI49.0
SupportA$27.58
ResistanceA$32.67
MA 20A$29.26
MA 50A$29.68
MA 200A$29.20
MACDBullish
VolumeIncreasing
Fear & Greed Index76.98

Valuation

Fair ValueA$14.98
Target PriceA$33.32
Upside/Downside13.26%
GradeOvervalued
TypeGrowth
Dividend Yield4.08%

Risk Assessment

Beta0.41
Volatility38.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.